Vioxx studies often used "ghost authors"

NEW YORK (Reuters Health) - A review of industry documents from the litigation surrounding Vioxx, the arthritis pain reliever that was withdrawn from the market by Merck, Inc. in 2004, reveals that clinical trials and review articles published about the drug were often written by company employees or other unacknowledged authors, while an...

Continue to Vioxx studies often used "ghost authors" on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz